Two doses of mumps vaccine as MMR are recommended at age 15 months and age 4 years.
Approximately 5 percent of children fail to be protected by the ﬁrst dose; of these, nearly all will be protected by the second (see section 11.4.2). The second dose can be given as soon as four weeks after the ﬁrst dose.
Children who in an outbreak receive MMR vaccine when aged under 12 months require two further doses administered after age 12 months. MMR vaccine may be given to children aged 12 months or older whose parents/guardians request it, and no opportunity should be missed to achieve immunity.
MMR is recommended and funded for older children and adults who are known to be susceptible to one or more of the three diseases (two doses, four weeks apart).
MMR is contraindicated in children who are immunosuppressed (see sections 1.4 and 4.3). They can be partially protected from exposure to infection by ensuring that all contacts are fully immunised, including hospital staff and family members. There is no risk of transmission of MMR vaccine viruses from a vaccinee to the immune-compromised individual.
MMR vaccination at 12 months of age is recommended for children with HIV infection who are asymptomatic and who are not severely immune compromised (see section 4.3).
MMR is contraindicated in children with severe immune suppression from HIV because vaccine-related pneumonitis (from the measles component) has been reported.7 Discuss vaccination of children with HIV infection with their specialist.
MMR vaccine is funded for (re-)vaccination following immunosuppression. However, this first must be discussed with the individual’s specialist.
MMR vaccine is contraindicated during pregnancy. Pregnancy should be avoided for four weeks after MMR vaccination.
MMR vaccine can be given to breastfeeding women.